Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Molecular & Cellular Oncology|February 16, 2017
Mutant p53-Nrf2 axis regulates the proteasome machinery in cancerKamil Lisek, Dawid Walerych, Giannino Del SalFrontiers in Oncology|January 7, 2016
Mutant p53: One, No One, and One Hundred ThousandDawid Walerych, Kamil Lisek, Giannino Del SalOncotarget|May 15, 2018
Mutant p53 tunes the NRF2-dependent antioxidant response to support survival of cancer cellsKamil Lisek, Elena Campaner, Yari Ciani, et al.Breast Cancer Research : BCR|April 2, 2022
Targeting SHP2 phosphatase in breast cancer overcomes RTK-mediated resistance to PI3K inhibitorsGuus J J E Heynen, Kamil Lisek, Regina Vogel, et al.Nature|March 4, 2015
Nuclear architecture dictates HIV-1 integration site selectionBruna Marini, Attila Kertesz-Farkas, Hashim Ali, et al.Cancer Research|February 12, 2021
YAP and β-Catenin Cooperate to Drive Oncogenesis in Basal Breast CancerHazel M Quinn, Regina Vogel, Oliver Popp, et al.Nature Cell Biology|December 20, 2017
Mechanical cues control mutant p53 stability through a mevalonate-RhoA axisEleonora Ingallina, Giovanni Sorrentino, Rebecca Bertolio, et al.Nature Cell Biology|June 28, 2016
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancerDawid Walerych, Kamil Lisek, Roberta Sommaggio, et al.Pageof 1